Renopharm Ltd.

Calculating rank

USPTO Granted Patents = 7

% Expired Patents = 100.0

Forward Citations = 86

Loading Chart...

3 inventors (with patents filed for the assignee):

Peter Assaf (7 out of 7 patents)

Michael Naveh (6 out of 7 patents)

Elham Gazaleen-Mariee (6 out of 6 patents)

7 patents: Sort by Forward Citations

1. 8134010 - Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof (2012-03-13),

2. 7968575 - Nitric oxide donors and uses thereof (2011-06-28),

3. 7579477 - Thiazole-based nitric oxide donors having alkyl substituent(s) and uses thereof (2009-08-25),

4. 7498445 - Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof (2009-03-03),

5. 7368577 - Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof (2008-05-06),

6. 7332513 - Thiazole-based nitric oxide donors having acyl substituent(s) and uses thereof (2008-02-19),

7. 7189750 - Thiazole-based nitric oxide donors having at least two thiazole moieties and uses thereof (2007-03-13),

Company Overview

Renopharm Ltd. is a leading pharmaceutical company specializing in the development and manufacturing of high-quality generic and branded medications. With a focus on innovation and customer satisfaction, Renopharm is committed to improving healthcare outcomes for patients worldwide. Our state-of-the-art facilities and experienced team ensure that our products meet the highest standards of safety and efficacy.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

7 Patents

#1 in Nazareth Illit

#912 in Israel

Nazareth Illit, Israel

Renopharm Ltd.

Forward Citations = 86

3 inventors:

Peter Assaf (7 out of 7 patents)

Michael Naveh (6 out of 7 patents)

Elham Gazaleen-Mariee (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Renopharm Ltd.. Retrieved from https://idiyas.com/company/renopharm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]